{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "techcrunch", "name": "TechCrunch"}, "author": "Maxwell Zeff", "title": "Someone bought the domain \u2018OGOpenAI\u2019 and redirected it to a Chinese AI lab - TechCrunch", "description": "A software engineer bought the website OGOpenAI.com and implemented a redirect to the website for the Chinese AI lab DeepSeek.", "url": "https://techcrunch.com/2025/01/22/someone-bought-the-domain-ogopenai-and-redirected-it-to-a-chinese-ai-lab/", "urlToImage": "https://techcrunch.com/wp-content/uploads/2025/01/GettyImages-2170386424.jpg?w=1024", "publishedAt": "2025-01-23T04:56:36Z", "content": "A software engineer has bought the website \u201cOGOpenAI.com\u201d and redirected it to DeepSeek, a Chinese AI lab that\u2019s been making waves in the open source AI world lately.\r\nSoftware engineer Ananay Arora \u2026 [+1501 chars]"}, {"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss \u201cMiracle Drugs\u201d - SciTechDaily", "description": "GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy, continues to rise. A recent study reve\u2026", "url": "https://scitechdaily.com/?p=451157", "urlToImage": "https://scitechdaily.com/images/Weight-Loss-Drugs-Scale.jpg", "publishedAt": "2025-01-23T03:57:00Z", "content": "GLP-1RA drugs like Ozempic offer significant health benefits, including weight loss, improved brain health, and reduced addiction risks, but also pose risks like pancreatitis and kidney issues. Resea\u2026 [+6141 chars]"}]}